期刊文献+

血清糖类抗原125、胸苷激酶-1、半乳激素-9水平与子宫内膜癌患者临床病理特征和预后的关系 被引量:5

Relationship between the Levels of Serum Carbohydrate Antigen 125,Thymidine Kinase-1 and Galectin-9 and Clinicopathological Features and Prognosis of Endometrial Carcinoma Patients
原文传递
导出
摘要 目的:探讨血清糖类抗原125(CA125)、胸苷激酶-1(TK1)、半乳激素-9(Gal-9)水平与子宫内膜癌(EC)患者临床病理特征和预后的关系。方法:选择2016年1月~2018年11月西北妇女儿童医院收治的EC患者114例作为研究组,同期医院体检的健康女性110例作为对照组。比较两组血清CA125、TK1、Gal-9水平及不同临床病理特征EC患者血清CA125、TK1、Gal-9水平。EC患者随访3年并绘制生存曲线,比较不同血清CA125、TK1、Gal-9水平患者预后情况,并应用Cox回归模型分析预后的影响因素。结果:研究组血清CA125、TK1、Gal-9水平显著高于对照组(P<0.05)。病理分期Ⅲ期、组织分化低分化、肌层浸润深度≥1/2、有淋巴结转移EC患者血清CA125、TK1、Gal-9水平显著高于病理分期Ⅰ~Ⅱ期、组织分化中高分化、肌层浸润深度<1/2、无淋巴结转移患者(P<0.05)。随访3年,失访8人,CA125高表达组3年生存率(50.00%)显著低于CA125低表达组(89.29%);TK1高表达组3年生存率(48.15%)显著低于TK1低表达组(94.23%);Gal-9高表达组3年生存率(46.67%)显著低于Gal-9低表达组(88.52%),差异均有统计学意义(P<0.05)。Cox比例风险回归分析显示血清CA125高表达、TK1高表达、Gal-9高表达,病理分期Ⅲ期、肌层浸润深度≥1/2、有淋巴结转移是EC患者死亡的影响因素(P<0.05)。结论:EC患者血清CA125、TK1、Gal-9异常升高,其水平与患者临床病理特征和预后有关,血清CA125、TK1、Gal-9高水平者预后较差。 Objective:To investigate the relationship between the levels of serum carbohydrate antigen 125(CA125),thymidine kinase-1(TK1),galectin-9(Gal-9)and the clinicopathological features and prognosis of endometrial carcinoma(EC)patients.Methods:114 cases of EC patients who were treated in Northwest women's and children's Hospital from January 2016 to November 2018 were selected as the study group,and 110 healthy women who underwent physical examination in the hospital in the same period were selected as the control group.The levels of serum CA125,TK1 and Gal-9 and the levels of serum CA125,TK1 and Gal-9 in EC patients with different clinicopathological features were compared between the two groups.EC patients were followed up for 3 years and the survival curve was drawn.The prognosis of patients with different serum CA125,TK1 and Gal-9 levels was compared,and the influencing factors of prognosis were analyzed by Cox regression model.Results:The levels of serum CA125,TK1 and Gal-9 in the study group were significantly higher than those in the control group(P<0.05).The levels of serum CA125,TK1 and Gal-9 in EC patients with pathological stage Ⅲ,low differentiation of tissue differentiation,depth of myometrial invasion≥1/2,with lymph node metastasis were significantly higher than those in patients with pathological stage Ⅰ~Ⅱ,medium and high differentiation of tissue differentiation,depth of myometrial invasion<1/2 and without lymph node metastasis(P<0.05).After 3 years of follow-up,8 people were lost,the 3-year survival rate of CA125 high expression group(50.00%)was significantly lower than that of CA125 low expression group(89.29%).The 3-year survival rate of TK1 high expression group(48.15%)was significantly lower than that of TK1 low expression group(94.23%).The 3-year survival rate(46.67%)in the Gal-9 high expression group was significantly lower than that in the Gal-9 low expression group(88.52%),the differences were statistically significant(P<0.05).Cox proportional hazards regression analysis showed that serum CA125 high expression,TK1 high expression and Gal-9 high expression,pathological stage Ⅲ,depth of myometrial invasion≥1/2 and with lymph node metastasis were the influencing factors of death in EC patients(P<0.05).Conclusion:The levels of serum CA125,TK1 and Gal-9 in EC patients are abnormally increased,which are related to the clinicopathological features and prognosis.The prognosis of patients with high levels of serum CA125,TK1 and Gal-9 is poor.
作者 顾琼雯 王贇 康茹 孟改利 杨怡楠 GU Qiong-wen;WANG Yun;KANG Ru;MENG Gai-li;YANG Yi-nan(Department of Clinical Laboratory,Northwest Women's and Children's Hospital,Xi'an,Shaanxi,710000,China;Department of Oncology,The Second Affiliated Hospital of Air Force Military Medical University,Xi'an,Shaanxi,710038,China)
出处 《现代生物医学进展》 CAS 2022年第20期3956-3961,共6页 Progress in Modern Biomedicine
基金 陕西省一般社会发展项目(2018SF-064)。
关键词 子宫内膜癌 糖类抗原125 胸苷激酶-1 半乳激素-9 临床病理特征 预后 Endometrial carcinoma Carbohydrate antigen 125 Thymidine kinase-1 Galectin-9 Clinicopathological features Prognosis
  • 相关文献

参考文献16

二级参考文献136

  • 1安宁,王建军.半乳凝素-9蛋白在肺腺癌、鳞癌中的表达及意义[J].中华临床医师杂志(电子版),2011,5(24):7374-7376. 被引量:3
  • 2Buys SS,Partridge E,Black A,et al. Effect of screening on ovari an cancer mortality., the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial[J]. JA- MA,2011,305(22) :2295.
  • 3Robertson DM,Klein R, de Vos FL, et al. The isolation of poly- peptides with FSH suppressing activity from bovine follicular flu id which are structurally different to inhibin[J]. Biochem Biophys Res Commun,1987,149(2) :744.
  • 4Ueno N, Ling N, Ying SY, et al. Isolation and partial characteriza- tion of follistatin~ a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone[J]. Proc Natl Acad Sci USA,1987,84(23)z8282.
  • 5Wakatsuki M, Shintani Y, Abe M, et al. mmunoradiometric assay for follistatinSerum Immunoreactive follistatin level in normal a- dult and pregnant women[J]. Clin Endocrinol Metab, 1996, 81 (2) :630.
  • 6Liu ZH, Shintani Y, Sakamoto Y, et al. Effects of LHRH, FSHand activin A on follistatin secretion from cultured rat anterior pi tuitary cells[J]. Endocrine, 1996,43(3) :321.
  • 7Brown PO,Palmer CThe preclinical natural history of serous o- varian cancer defining the target for early detection[J]. PLoS Med, 2009,6 (7) : el000114.
  • 8Kobayashi H, Yamada Y, Sado T, et al. A randomized study of screening for ovarian cancer;a multicenter study in Japan[J]. Int J Gynecol Cancer,2008,18(3):414.
  • 9Schneyer AL, Fujiwara T, Fox J, et al. Dynamic changes in the in trafollicular inhibin/activin/follistatin axis during human follicu lar developmentrelationship to circulating hormone concentra- tions[J]. Clin Endocrinol Metab, 2000,85 (9) : 3319.
  • 10Harrison CA, Gray PC, Vale WW, et al. Antagonists of activin signaling: mechanisms and potential biological applications [ J ]. Trends Endocrinol Metab,2005,16(2) :73.

共引文献210

同被引文献76

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部